Invuity Announces Definitive Agreement to Be Acquired by Stryker for $7.40 Per Share in Cash Medical Device Investing
Viveve Submits Investigational Device Exemption to FDA to Conduct LIBERATE-U.S. Trial for Improvement of Stress Urinary Incontinence Medical Device Investing
KemPharm Announces Positive Topline Results from Oral Human Abuse Potential Trial of KP415 Prodrug Pharmaceutical Investing
IMV Announces Phase 2 Basket Trial in Collaboration with Merck to Evaluate DPX-Survivac in Combination with KEYTRUDA Across Five Solid Tumor Indications Biotech Investing
Nu-Med Plus Announces Prominent Research Lab to Utilize its New Advanced Nitric Oxide Delivery Product for Study Medical Device Investing
IRADIMED Announces Clearance of MRI Compatible Patient Vital Signs Monitor in Japan Medical Device Investing
NanoSphere Health Sciences Expands to Indiana With Evolve Formulas NanoSerum™ Hemp Cannabis Investing News
Amicus Therapeutics Announces Regulatory and Clinical Updates for AT-GAA in Pompe Disease Biotech Investing
Cyclacel Pharmaceuticals Announces Initiation of Phase 1b/2 Clinical Trial of Sapacitabine With Olaparib in BRCA Mutant Breast Cancer Pharmaceutical Investing
BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026
